Stock Chart

Stock Chart

Zosano Pharma Corp(ZSAN)

NASDAQ CAPITAL MARKET

$0.9178

-0.0063(-0.682%)

ZSAN Company Profile

34790 Ardentech Ct

Fremont, California 94555-3657
15107451200
www.zosanopharma.com
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Full Time Employees:

Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing products where rapid administration of approved molecules with established safety and efficacy profiles may provide substantial benefit to patients, in markets where patients remain underserved by existing therapies. The company's transdermal microneedle system technology consists of titanium microneedles coated with drug that are designed to enable rapid systemic administration of therapeutics to patients. Zosano's lead product candidate is Qtrypta™ (M207), which is a proprietary formulation of zolmitriptan designed to be delivered via its transdermal microneedle system technology, as an acute treatment for migraine.

  • Previous Close
    0.9241
  • Open
    0.93
  • Bid
    0
  • Ask
    0
  • Day's Range
    0.8788 - 0.93
  • 52 week Range
    0.3275 - 3.06
  • Volume
    1542897
  • Avg. Volume
    3581101
  • Market Cap
    97955299
  • Beta (5Y Monthly)
    0.93
  • PE Ratio (TTM)
  • EPS (TTM)
    0
  • Earnings Date
    0.93
  • Forward Dividend & Yield
    0.93
  • Ex-Dividend Date
    1542897
  • 1y Target Est
    0.93

KEEP ME INFORMED ON ZSAN UPDATES

ZSAN Performance

  • 5 Day
    -12.820754716981%
  • 1 Month
    22.267795713152%
  • 3 Month
    -34.922535211268%
  • YTD
    75.317776512996%
  • 1 Year
    9.750593824228%

ZSAN on Twitter

ZSAN on iHub

ZSAN News

/*
  • */